SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-023885
Filing Date
2021-02-16
Accepted
2021-02-16 16:04:42
Documents
14
Period of Report
2021-02-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm216705d1_8k.htm   iXBRL 8-K 28187
2 EXHIBIT 99.1 tm216705d1_ex99-1.htm EX-99.1 50977
6 GRAPHIC tm2167051_ex99-1img01.jpg GRAPHIC 2684
  Complete submission text file 0001104659-21-023885.txt   268874

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA epix-20210211.xsd EX-101.SCH 2763
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE epix-20210211_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epix-20210211_pre.xml EX-101.PRE 22715
7 EXTRACTED XBRL INSTANCE DOCUMENT tm216705d1_8k_htm.xml XML 3801
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 21638000
SIC: 2834 Pharmaceutical Preparations